Early Investors set to win big as FDA fast-tracks this ancient medicine

And it’s completely natural. [From Silicon Valley to Wall Street...]( An ancient medicine is helping keep some of the smartest people on the planet on their toes. It’s also prompted the FDA to fast-track this ‘miracle compound’ for approval. It’s effective in treating a wide array of medical conditions, including depression, anxiety and even PTSD… [And it’s completely natural.]( It has the potential to completely transform the mental health industry… An industry that’s projected to be worth $260 billion in the next few years. And one small company is leading the push...looking to corner the market as it takes off across the country. [Read the full detailed report here.](  ________________________________________________________________________ Sir Isaac Publishing, an affiliate and partner company of IRPub LLC, and IRPub LLC, have received Forty-Thousand Dollars paid by a third party, Global Investment Daily for and on behalf of Lobe Sciences Ltd. (CSE:LOBE ; OTC:GTSIF) for brand awareness, marketing distribution and investor education marketing for a period of 5 days. Sir Isaac Publishing has not received any shares, nor owns any shares ofLobe Sciences Ltd. (CSE:LOBE ; OTC:GTSIF) For a full disclaimer | disclosure please [click here.](  This communication is a paid advertisement and is not a recommendation to buy or sell securities. IRPub LLC, and its owners, managers, employees, and assigns (collectively “the Company”) has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by Global Investment Daily, for and on behalf of Lobe Sciences Ltd., Forty-Thousand US dollars for email marketing for a period of 5 days. This compensation is a major conflict with our ability to be unbiased, more specifically: This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in this article, in our newsletter and on our website may be based on end-of-day or intraday data. We have been compensated by Lobe Sciences Ltd. (CSE: LOBE | OTC: GTSIF) to conduct investor awareness advertising and marketing.   Therefore, this communication should be viewed as a commercial advertisement only. We have not thoroughly investigated the background of GTSIF. The third party, profiled company, or their affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our alerts experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct.   NOT AN INVESTMENT ADVISOR. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation.   ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.   INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.   RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher. If you are you having trouble receiving your Investr subscription, you can ensure its arrival in your mailbox by [whitelisting Investr and membersupport@investr.info.]( Investr (collectively, the “Company” or “we” used herein) bears no responsibility or control over the content of the advertisement and/or the product or service offered. This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by Investr and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. There is a very high degree of risk involved in trading. Past results are not indicative of future returns. Investr, all individuals and companies affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as advice. Information for any trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. By reading, downloading or otherwise consuming this content your information may be shared with our educational partners. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of Investr may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.  Your subscriber Id is: c35b5090289a030d5f71723db89dd233 Proudly brought to you by: Investr of 3rd Fl, N&S Tower, 4 Selsdon Way, London, E14 9GL, UK In order to unsubscribe from this mailing list, please click [here](